Cosmos Health Operating Income Over Time
| COSM Stock | USD 0.39 0.03 9.14% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Cosmos Health Performance and Cosmos Health Correlation. Will Health Care Providers & Services sector continue expanding? Could Cosmos diversify its offerings? Factors like these will boost the valuation of Cosmos Health. Projected growth potential of Cosmos fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Cosmos Health data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.77) | Revenue Per Share | Quarterly Revenue Growth 0.379 | Return On Assets | Return On Equity |
Investors evaluate Cosmos Health using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Cosmos Health's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Cosmos Health's market price to deviate significantly from intrinsic value.
It's important to distinguish between Cosmos Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cosmos Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Cosmos Health's market price signifies the transaction level at which participants voluntarily complete trades.
Cross Equities Operating Income Analysis
Compare Cosmos Health and related stocks such as Femasys, Scynexis, and Clearside Biomedical Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FEMY | (11.6 M) | (11.6 M) | (11.6 M) | (11.6 M) | (11.6 M) | (11.6 M) | (11.6 M) | (11.6 M) | (11.6 M) | (11.6 M) | (6.9 M) | (8.3 M) | (11.6 M) | (14.5 M) | (17.8 M) | (16 M) | (16.8 M) |
| SCYX | (7.8 M) | (7.8 M) | (7.8 M) | (7.2 M) | (14.6 M) | (28.3 M) | (27.8 M) | (26.3 M) | (30 M) | (48.9 M) | (51.1 M) | (60.8 M) | (85.8 M) | 72.7 M | (37.1 M) | (33.4 M) | (35.1 M) |
| LSTA | (1.5 M) | (34 M) | (30.4 M) | (36.8 M) | (57.7 M) | (51.6 M) | (31.3 M) | (27.6 M) | (17 M) | (20.1 M) | (19.1 M) | (29.1 M) | (57.6 M) | (25.7 M) | (22.4 M) | (20.2 M) | (21.2 M) |
| NXGL | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (969 K) | (1.9 M) | (1.9 M) | (2.3 M) | (2.6 M) | (3.3 M) | (3.5 M) | (3.6 M) | (3.2 M) | (3.4 M) |
| MTVA | (266 K) | (266 K) | (266 K) | (266 K) | (266 K) | (8.1 M) | (14.7 M) | (33.1 M) | (15.5 M) | (20.2 M) | (29.7 M) | (15.3 M) | (19.6 M) | (15.9 M) | (28.8 M) | (25.9 M) | (27.2 M) |
| PASG | (13.5 M) | (13.5 M) | (13.5 M) | (13.5 M) | (13.5 M) | (13.5 M) | (13.5 M) | (13.5 M) | (13.5 M) | (37.2 M) | (112.9 M) | (185.7 M) | (138.4 M) | (100.1 M) | (70.4 M) | (63.4 M) | (66.5 M) |
| CASI | (20 K) | (4.6 M) | 4.5 M | 5.7 M | 26.2 M | 7.2 M | 9.4 M | (10.8 M) | (26.5 M) | (40 M) | (52.8 M) | (41.5 M) | (26.5 M) | (25.1 M) | (39.6 M) | (35.7 M) | (33.9 M) |
| NCNA | (7.6 K) | (7.6 K) | (7.6 K) | (7.6 K) | (7.6 K) | (6.9 M) | (8.4 M) | (22.2 M) | (22 M) | (26.7 M) | (32.9 M) | (45.3 M) | (43.7 M) | (32.8 M) | (22.8 M) | (20.5 M) | (21.6 M) |
| IINN | (39.6 K) | (39.6 K) | (39.6 K) | (39.6 K) | (39.6 K) | (39.6 K) | (39.6 K) | (39.6 K) | (39.6 K) | (1.3 M) | (6.3 M) | (12.2 M) | 14.9 M | (12.1 M) | 11.3 K | 10.1 K | 10.6 K |
Cosmos Health and related stocks such as Femasys, Scynexis, and Clearside Biomedical Operating Income description
Operating Income is the amount of profit realized from Cosmos Health operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Cosmos Health is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Cosmos Health | COSM |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 141 West Jackson |
| Exchange | NASDAQ Exchange |
USD 0.3929
Check out Cosmos Health Performance and Cosmos Health Correlation. To learn how to invest in Cosmos Stock, please use our How to Invest in Cosmos Health guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Cosmos Health technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.